Merestinib (LY2801653) inhibits neurotrophic receptor kinase (NTRK) and suppresses growth of NTRK fusion bearing tumors
Merestinib (LY2801653) 可抑制神经营养受体激酶 (NTRK)，并抑制携带 NTRK 融合基因的肿瘤的生长。
期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.24488
Konicek, Bruce W; Capen, Andrew R; Credille, Kelly M; Ebert, Philip J; Falcon, Beverly L; Heady, Gary L; Patel, Bharvin K R; Peek, Victoria L; Stephens, Jennifer R; Stewart, Julie A; Stout, Stephanie L; Timm, David E; Um, Suzane L; Willard, Melinda D; Wulur, Isabella H; Zeng, Yi; Wang, Yong; Walgren, Richard A; Betty Yan, Sau-Chi
